Iron Therapy
Iron deficiency (ID) is one of the most common co-morbidities in patients with heart failure (HF). It has its highest prevalence in elderly subjects, women, decompensated subjects, and patients with numerous co-morbidities. ID is associated with worse symptoms, poorer quality of life, reduced exerci...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Barcaray International
2019-01-01
|
| Series: | International Cardiovascular Forum Journal |
| Subjects: | |
| Online Access: | https://icfjournal.org/index.php/icfj/article/view/625/pdf |
| id |
doaj-d413b13a8e71484a990fe4f5fd1fbed1 |
|---|---|
| record_format |
Article |
| spelling |
doaj-d413b13a8e71484a990fe4f5fd1fbed12020-11-25T03:57:04ZengBarcaray InternationalInternational Cardiovascular Forum Journal2410-26362409-34242019-01-01183640https://doi.org/10.17987/icfj.v18i0.625Iron TherapyEwa A Jankowska0Marcin Drozd1Michał Tkaczyszyn2Piotr Ponikowsk3Department of Heart Diseases, Wroclaw Medical University, PolandDepartment of Heart Diseases, Wroclaw Medical University, PolandDepartment of Heart Diseases, Wroclaw Medical University, PolandDepartment of Heart Diseases, Wroclaw Medical University, PolandIron deficiency (ID) is one of the most common co-morbidities in patients with heart failure (HF). It has its highest prevalence in elderly subjects, women, decompensated subjects, and patients with numerous co-morbidities. ID is associated with worse symptoms, poorer quality of life, reduced exercise capacity, and a high morbidity and mortality. Both ID and the anaemia it can lead to can be harmful in HF. Repletion of iron stores has been shown to be effective in HF and detection and treatment of ID are now recommended in major HF guidelines. This paper summarises iron therapy for ID in HF patients.https://icfjournal.org/index.php/icfj/article/view/625/pdfheart failureironiron deficiencyanaemiairon supplementation therapy |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Ewa A Jankowska Marcin Drozd Michał Tkaczyszyn Piotr Ponikowsk |
| spellingShingle |
Ewa A Jankowska Marcin Drozd Michał Tkaczyszyn Piotr Ponikowsk Iron Therapy International Cardiovascular Forum Journal heart failure iron iron deficiency anaemia iron supplementation therapy |
| author_facet |
Ewa A Jankowska Marcin Drozd Michał Tkaczyszyn Piotr Ponikowsk |
| author_sort |
Ewa A Jankowska |
| title |
Iron Therapy |
| title_short |
Iron Therapy |
| title_full |
Iron Therapy |
| title_fullStr |
Iron Therapy |
| title_full_unstemmed |
Iron Therapy |
| title_sort |
iron therapy |
| publisher |
Barcaray International |
| series |
International Cardiovascular Forum Journal |
| issn |
2410-2636 2409-3424 |
| publishDate |
2019-01-01 |
| description |
Iron deficiency (ID) is one of the most common co-morbidities in patients with heart failure (HF). It has its highest prevalence in elderly subjects, women, decompensated subjects, and patients with numerous co-morbidities. ID is associated with worse symptoms, poorer quality of life, reduced exercise capacity, and a high morbidity and mortality. Both ID and the anaemia it can lead to can be harmful in HF. Repletion of iron stores has been shown to be effective in HF and detection and treatment of ID are now recommended in major HF guidelines. This paper summarises iron therapy for ID in HF patients. |
| topic |
heart failure iron iron deficiency anaemia iron supplementation therapy |
| url |
https://icfjournal.org/index.php/icfj/article/view/625/pdf |
| work_keys_str_mv |
AT ewaajankowska irontherapy AT marcindrozd irontherapy AT michałtkaczyszyn irontherapy AT piotrponikowsk irontherapy |
| _version_ |
1724462081430781952 |